Guillermo Arreaza

Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes

Shayan Sharif, Guillermo Arreaza, Peter Zucker et al. · Nature Medicine · 2001 · 599 citations

Life Sciences, Endocrinology, Immunology +11

IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function

Mark J. Cameron, Guillermo Arreaza, Peter Zucker et al. · The Journal of Immunology · 1997 · 224 citations · Full text

Life Sciences, Endocrinology, Immunology +17

Differential Expression of CC Chemokines and the CCR5 Receptor in the Pancreas Is Associated with Progression to Type I Diabetes

Mark J. Cameron, Guillermo Arreaza, Marsha Grattan et al. · The Journal of Immunology · 2000 · 143 citations

Life Sciences, Immunology, Pathology +17

Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism.

Guillermo Arreaza, Mark J. Cameron, Andrés Jaramillo et al. · Journal of Clinical Investigation · 1997 · 84 citations · Full text

Life Sciences, Endocrinology, Immunology +16

Insulin B-chain reactive CD4+ regulatory T-cells induced by oral insulin treatment protect from type 1 diabetes by blocking the cytokine secretion and pancreatic infiltration of diabetogenic effector T-cells.

Isabelle Bergerot, Guillermo Arreaza, Mark J. Cameron et al. · Diabetes · 1999 · 68 citations

Life Sciences, Endocrinology, Immunology +17